Our primary product is a distinct Canadian-formulated medication aimed at general health, men’s health, and family health. This groundbreaking drug, influenced by the dual mechanism selective CYP17 lyase and androgen receptor (AR) inhibitors, is tailored for the online pharmacy model. Innocrin pharmacy guarantees that clients can effortlessly obtain safe and efficient medications for their healthcare requirements.
The active component in our product originates from a class of antiparasitic agents akin to macrolide antibiotics, but it lacks antibacterial properties. It is administered orally for various health concerns and applied topically for head lice or rosacea. Resistance to this active compound has not been reported, ensuring its ongoing efficacy.
Our Canadian-created medication is a non-steroidal, orally active, small molecule that is taken once daily to inhibit sex steroid production. In over 100 men and women treated, it has not exhibited any cardiac signals or liver enzyme elevations, suggesting the possibility of combining it with other complementary drug classes showing promise.
This cutting-edge drug is presently undergoing a Phase 2 clinical trial to treat individuals with diverse health conditions related to general health, men’s health, and family health. Our Phase 2 initiatives concentrate on advanced health challenges that signify considerable unmet medical needs for both women and men. The goal is to offer accessible and effective treatment solutions through our online pharmacy platform.